Polymedic

Visit Website
Investment Strategy
Industry
Current or past
Date of investment
Transaction Type
Country
Sector
Private Equity
Healthcare
Current (November 2019)
November 2019
Buyout
Morocco
Healthcare -Pharmaceuticals

NBK Capital Equity Partners Fund II

Founded in 2001, Polymedic is a leading Morocco-based generics pharmaceutical manufacturer. The Company has a diversified portfolio of over 200 products across 12 therapeutic areas. Polymedic has a Morocco GMP-approved facility producing various forms and drug doses.

other investments
Investment Strategies
Private Credit
Flexible financing solutions
Private Equity
The flagship strategy of NBK Capital Partners
Real Estate
Stable rental yield to investors
Investment Strategies
UAE
Dubai
Turkey
Istanbul
Kuwait
Sharq
Bahrain
Manama